Canada markets open in 1 hour 56 minutes

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.8300+0.0600 (+2.17%)
At close: 04:00PM EDT
2.8300 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 199.33M
Enterprise Value 127.78M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.76
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.92
52-Week Change 317.92%
S&P500 52-Week Change 328.04%
52 Week High 34.0000
52 Week Low 30.9700
50-Day Moving Average 33.0010
200-Day Moving Average 32.1230

Share Statistics

Avg Vol (3 month) 3241.88k
Avg Vol (10 day) 3129.64k
Shares Outstanding 570.44M
Implied Shares Outstanding 670.44M
Float 840.83M
% Held by Insiders 11.26%
% Held by Institutions 177.84%
Shares Short (Apr 30, 2024) 41.05M
Short Ratio (Apr 30, 2024) 44.2
Short % of Float (Apr 30, 2024) 42.45%
Short % of Shares Outstanding (Apr 30, 2024) 41.50%
Shares Short (prior month Mar 28, 2024) 41.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.56%
Return on Equity (ttm)-38.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.13M
Net Income Avi to Common (ttm)-33.57M
Diluted EPS (ttm)-0.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)72.82M
Total Cash Per Share (mrq)1.03
Total Debt (mrq)1.27M
Total Debt/Equity (mrq)1.76%
Current Ratio (mrq)14.55
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)-33.98M
Levered Free Cash Flow (ttm)-22.58M